Advanced in Acute Myeloblastic Leukemia without Maturation

Catalin D. Danaila

Iasi, IS, RO 
Advanced in Acute Myeloblastic Leukemia without Maturation
Iasi, IS, RO 
OverviewLocationsClinical Research

Overview

Catalin Danaila practices in Iasi, Romania. Ms. Danaila is rated as an Advanced expert by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. Her top areas of expertise are Acute Myeloblastic Leukemia with Maturation, Acute Myeloblastic Leukemia without Maturation, Leukemia, and Acute Myeloid Leukemia (AML).

Her clinical research consists of co-authoring 10 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Acute Myeloblastic Leukemia without Maturation.

Gender
Female

Locations

Iasi, IS, Romania

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 3 Randomized, Controlled, Open-label Study of Selinexor, Bortezomib, and Dexamethasone (SVd) Versus Bortezomib and Dexamethasone (Vd) in Patients With Relapsed or Refractory Multiple Myeloma (RRMM)
A Phase 3 Randomized, Controlled, Open-label Study of Selinexor, Bortezomib, and Dexamethasone (SVd) Versus Bortezomib and Dexamethasone (Vd) in Patients With Relapsed or Refractory Multiple Myeloma (RRMM)
Enrollment Status: Completed
Publish Date: August 21, 2024
Intervention Type: Drug
Study Drugs: Selinexor, Bortezomib, Dexamethasone
Study Phase: Phase 3

10 Total Publications

Disease Characteristics and Treatment Outcomes of Myeloma Patients Under 50 Years of Age: An Analysis of the Balkan Myeloma Study Group.
Disease Characteristics and Treatment Outcomes of Myeloma Patients Under 50 Years of Age: An Analysis of the Balkan Myeloma Study Group.
Journal: Clinical lymphoma, myeloma & leukemia
Published: November 18, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Danaila's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile